Beximco Sees Turbulence From COVID-19

Remdesivir Success Is Accompanied By Supply Chain Disruption

A mixed picture has emerged for Beximco in its financial third quarter as a result of the coronavirus pandemic, with its success launching the first generic of remdesivir balanced by disruption to the supply chain.

Carousel
The turbulence of COVID-19 has provided swings and roundabouts for Beximco • Source: Shutterstock

Bangladesh’s Beximco has seen mixed fortunes in the wake of the COVID-19 pandemic, pointing to a disruptive effect on the firm’s distribution network and supply chain.

The turbulence was felt despite the firm ultimately registering double-digit growth both in its financial third quarter and nine months...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business